Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 620974, 8 pages
http://dx.doi.org/10.1155/2014/620974
Research Article

Evaluation of Preclinical Assays to Investigate an Anthroposophic Pharmaceutical Process Applied to Mistletoe (Viscum album L.) Extracts

1Hiscia Institute, Society for Cancer Research, Kirschweg 9, 4144 Arlesheim, Switzerland
2Institute of Integrative Medicine, Gemeinschaftskrankenhaus, University of Witten-Herdecke, Gerhard-Kienle-Weg 4, 58313 Herdecke, Germany
3Institute of Complementary Medicine, Inselspital, University of Bern, Imhoof-Pavillon, 3010 Bern, Switzerland

Received 17 September 2013; Accepted 11 March 2014; Published 4 May 2014

Academic Editor: Steven Rosenzweig

Copyright © 2014 Stephan Baumgartner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Steiner, “Geisteswissenschaft und Medizin, 13th lecture, Dornach, 2. April 1920,” in Geisteswissenschaft und Medizin, H. W. Zbinden, Ed., pp. 210–227, Rudolf-Steiner Nachlassverwaltung, Dornach, Switzerland, 4th edition, 1961. View at Google Scholar
  2. R. Steiner and I. Wegman, Grundlegendes für eine Erweiterung der Heilkunst nach geisteswissenschaftlichen Erkenntnissen, Rudolf-Steiner, Dornach, Switzerland, 1925.
  3. A. Büssing, “Biological and pharmacological properties of Viscum album L.,” in Mistletoe: The Genus Viscum, A. Büssing, Ed., pp. 123–182, Harwood Academic, Amsterdam, The Netherlands, 2000. View at Google Scholar
  4. G. S. Kienle and H. Kiene, Die Mistel in der Onkologie, Schattauer, Stuttgart, Germany, 2003.
  5. J. Maldacker, “Preclinical investigations with mistletoe (Viscum album L.) extract Iscador,” Arzneimittel-Forschung, vol. 56, no. 6, pp. 497–507, 2006. View at Google Scholar · View at Scopus
  6. T. Ostermann, C. Raak, and A. Büssing, “Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review,” BMC Cancer, vol. 9, article 451, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. G. S. Kienle and H. Kiene, “Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts,” European Journal of Medical Research, vol. 12, no. 3, pp. 103–119, 2007. View at Google Scholar · View at Scopus
  8. J. Melzer, F. Iten, K. Hostanska, and R. Saller, “Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases,” Forschende Komplementärmedizin, vol. 16, no. 4, pp. 217–226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. G. S. Kienle, R. Grugel, and H. Kiene, “Safety of higher dosages of Viscum album L. in animals and humans—systematic review of immune changes and safety parameters,” BMC Complementary & Alternative Medicine, vol. 11, article 72, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Büssing, “Overview of Viscum album L. products,” in Mistletoe: The Genus Viscum, A. Büssing, Ed., pp. 209–221, Harwood Academic, Amsterdam, The Netherlands, 2000. View at Google Scholar
  11. R. Leroi, “Die Mischung der Mistelsäfte—angaben Rudolf Steiners,” Beiträge zu einer Erweiterung der Heilkunst, vol. 40, pp. 238–247, 1987. View at Google Scholar
  12. D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Levin, “Morphogenetic fields in embryogenesis, regeneration, and cancer: non-local control of complex patterning,” Biosystems, vol. 109, no. 3, pp. 243–261, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. Soto and C. Sonnenschein, “The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory,” Bioessays, vol. 33, no. 5, pp. 332–340, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Heusser, “Führt die Molekularbiologie zu einem neuen Konzept des Organismus? Das Beispiel der Karzinogenese,” Forschende Komplementärmedizin und Klassische Naturheilkunde, vol. 4, no. 2, pp. 106–111, 1997. View at Google Scholar · View at Scopus
  17. G. S. Kienle and H. Kiene, “From reductionism to holism: systems-oriented approaches in cancer research,” Global Advances in Health and Medicine, vol. 1, pp. 68–77, 2012. View at Google Scholar
  18. P. Heusser and G. S. Kienle, “Anthroposophic medicine, integrative oncology, and mistletoe therapy of cancer,” in Integrative Oncology, D. Abrams and A. Weil, Eds., pp. 322–340, Oxford University Press, New York, NY, USA, 2009. View at Google Scholar
  19. J. Ritchie, J. Wilkinson, M. Gantley, G. Feder, Y. Carter, and J. Formby, A Model of Integrated Primary Care: Anthroposophic Medicine, Queen Mary, University of London, London, UK, 2001.
  20. G. Unger, “Kurze Geschichte der Heilmittelzentrifuge des Institutes Hiscia unter Einbeziehung der Hinweise Rudolf Steiners zur Erstellung der Mistelpräparate,” in Misteltherapie—Eine Antwort auf die Herausforderung Krebs, R. Leroi, Ed., pp. 45–57, Freies Geistesleben, Stuttgart, Germany, 1987. View at Google Scholar
  21. H. Musielski and K. Rüger, “Verfahren zur quantitativen Bestimmung von Mistellektin I und Mistellektin II und/oder Mistellektin III in Mistelextrakten unter Verwendung monoklonaler Antikörper, die spezifisch mit Mistellektin reagieren,” in Grundlagen der Misteltherapie, R. Scheer, H. Becker, and P. A. Berg, Eds., pp. 95–104, Hippokrates, Stuttgart, Germany, 1996. View at Google Scholar
  22. M. Ishiyama, H. Tominaga, M. Shiga, K. Sasamoto, Y. Ohkura, and K. Ueno, “A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet,” Biological & Pharmaceutical Bulletin, vol. 19, no. 11, pp. 1518–1520, 1996. View at Google Scholar · View at Scopus
  23. S. G. Carmer and M. R. Swanson, “An evaluation of ten pairwise multiple comparison procedures by Monte Carlo methods,” Journal of the American Statistical Association, vol. 68, pp. 66–74, 1973. View at Google Scholar
  24. S. Baumgartner, H. Flückiger, C. Jäggy, G. Schaller, D. S. Rossi, and K. Urech, “Untersuchung des Iscador-Maschinenprozesses in Modellsystemen der Zytotoxikologie und Phytopathologie,” in Fortschritte in der Misteltherapie—Aktueller Stand der Forschung und Klinische Anwendung, R. Scheer, R. Bauer, H. Becker, V. Fintelmann, F. H. Kemper, and H. Schilcher, Eds., pp. 169–179, KVC, Essen, Germany, 2005. View at Google Scholar
  25. O. Janssen, A. Scheffler, and D. Kabelitz, “In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis),” Arzneimittel-Forschung, vol. 43, no. 11, pp. 1221–1227, 1993. View at Google Scholar · View at Scopus
  26. K. Urech, G. Schaller, P. Ziska, and M. Giannattasio, “Comparative study on the cytotoxic effect of viscotoxin and mistletoe lectin on tumour cells in culture,” Phytotherapy Research, vol. 9, no. 1, pp. 49–55, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Urech, G. Schaller, and C. Jäggy, “Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador: analytical results on pharmaceutical processing of mistletoe,” Drug Research, vol. 56, no. 6, pp. 428–434, 2006. View at Google Scholar · View at Scopus
  28. R. L. Margolis and L. Wilson, “Addition of colchicine tubulin complex to microtubule ends: the mechanism of substoichiometric colchicine poisoning,” Proceedings of the National Academy of Sciences of the United States of America, vol. 74, no. 8, pp. 3466–3470, 1977. View at Google Scholar · View at Scopus
  29. T. Butterfass, Wachstums-und Entwicklungsphysiologie der Pflanze, Quelle & Meyer, Heidelberg, Germany, 1970.
  30. A. F. Blakeslee and A. G. Avery, “Methods of inducing doubling of chromosomes in plants,” The Journal of Heredity, vol. 28, pp. 393–412, 1937. View at Google Scholar
  31. A. Levan, “The effect of colchicine on root mitosis in Allium,” Hereditas, vol. 24, pp. 471–486, 1938. View at Google Scholar
  32. H. Flückiger and S. Baumgartner, “Auswirkung des Iscador-Maschinenprozesses auf Mistelextrakte in botanischen Untersuchungssystemen,” Der Merkurstab, vol. 56, pp. 114–121, 2003. View at Google Scholar
  33. A. Büssing, A. Lehnert, M. Schink, R. Mertens, and K. Schweizer, “Effect of Viscum album L. on rapidly proliferating amniotic fluid cells. Sister chromatid exchange frequency and proliferation index,” Arzneimittel-Forschung, vol. 45, no. 1, pp. 81–83, 1995. View at Google Scholar · View at Scopus
  34. E. Kovacs, “The in vitro effect of Viscum album (VA) extract on DNA repair of peripheral blood mononuclear cells (PBMC) in cancer patients,” Phytotherapy Research, vol. 16, no. 2, pp. 143–147, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Burkhart, C. Wälchli, P. Heusser, U. Weissenstein, S. Baumgartner, and A.-C. Andres, “In vitro investigation into the potential of a mistletoe extract to alleviate adverse effects of cyclophosphamide,” Alternative Therapies in Health and Medicine, vol. 16, no. 3, pp. 40–48, 2010. View at Google Scholar · View at Scopus
  36. R. Rentea, E. Lyon, and R. Hunter, The Modulation of the Immune Response by Viscum album Proteins, Iscador, Department of Pathology and Surgery, University of Chicago Hospitals and Clinics, Chicago, Ill, USA, 1976.
  37. G. Kuttan, L. G. Menon, and R. Kuttan, “Prevention of 20-methylcholanthrene-induced sarcoma by a mistletoe extract, Iscador,” Carcinogenesis, vol. 17, no. 5, pp. 1107–1109, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Kuttan and R. Kuttan, “Reduction of leukopenia in mice by “Viscum album” administration during radiation and chemotherapy,” Tumori, vol. 79, no. 1, pp. 74–76, 1993. View at Google Scholar · View at Scopus
  39. E. Kovacs, T. Hajto, and K. Hostanska, “Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador),” European Journal of Cancer, vol. 27, no. 12, pp. 1672–1676, 1991. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Bar-Sela, M. Wollner, L. Hammer, A. Agbarya, E. Dudnik, and N. Haim, “Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study,” European Journal of Cancer, vol. 49, no. 5, pp. 1058–1064, 2013. View at Publisher · View at Google Scholar
  41. H. Matthes, W. E. Friedel, P. R. Bock, and K. S. Zänker, “Molecular mistletoe therapy: friend or foe in established antitumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancer,” Current Molecular Medicine, vol. 10, no. 4, pp. 430–439, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. W. E. Friedel, H. Matthes, P. R. Bock, and K. S. Zänker, “Systematic evaluation of the clinical effects of supportive mistletoe treatment within chemo- and/or radiotherapy protocols and long-term mistletoe application in nonmetastatic colorectal carcinoma: multicenter, controlled, observational cohort study,” Journal of the Society for Integrative Oncology, vol. 7, no. 4, pp. 137–145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. P. R. Bock, W. E. Friedel, J. Hanisch, M. Karasmann, and B. Schneider, “Wirksamkeit und Sicherheit der komplementären Langzeitbehandlung mit einem standardisierten Extrakt aus Europäischer Mistel (Viscum album L.) zusätzlich zur konventionellen adjuvanten onkologischen Therapie bei primärem, nicht metastasiertem Mammakarzinom,” Drug Research, vol. 54, pp. 456–466, 2004. View at Google Scholar